PP_1170x120_10-25-21

Katie McNichol is client insights principal for health care at IRI

New landscape could propel Rx-to-O-T-C switches

New landscape could propel Rx-to-O-T-C switches

While the majority of consumers regularly rely on nonprescription medicines for self-care, the use of over-the-counter products intensified even further during the COVID-19 pandemic. Since the start of Rx-to-O-T-C switching more than 40 years ago, many obvious switch candidates — from pain relievers like Advil to allergy meds like Claritin, Zyrtec and Flonase — have

Adheris Health